← FDA DRUG APPROVALS

FDA ANDA · ANDA072059

PANCURONIUM BROMIDE

Sponsor: ELKINS SINN

APPLICATION
ANDA072059
TYPE
ANDA
ORIGINAL APPROVAL
1988-03-23
LATEST ACTION
2001-09-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PANCURONIUM BROMIDEDiscontinued
PANCURONIUM BROMIDE 2MG/ML · INJECTABLE · INJECTION

Approval history

2001-09-10Manufacturing (CMC) · Supplement 15AP
2001-09-05Manufacturing (CMC) · Supplement 13AP
2000-04-12Manufacturing (CMC) · Supplement 14AP
1998-11-02Manufacturing (CMC) · Supplement 11AP
1993-11-18Manufacturing (CMC) · Supplement 10AP
1993-02-19Labeling · Supplement 9AP
1991-06-07Manufacturing (CMC) · Supplement 7AP
1989-12-08Labeling · Supplement 5AP
1989-01-11Labeling · Supplement 4AP
1988-10-19Manufacturing (CMC) · Supplement 3AP
1988-10-19Manufacturing (CMC) · Supplement 2AP
1988-09-01Manufacturing (CMC) · Supplement 1AP
1988-03-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →